JAK2 inhibition is neuroprotective and reduces astrogliosis after quinolinic acid striatal lesion in adult mice

Journal of Chemical Neuroanatomy

Volumn 48-49, Issue , 2013, Pages 14-22

  Ignarro, Raffaela Silvestre ^a   Vieira, André Schwambach ^a   Sartori, Cesar Renato ^a   Langone, Francesco ^a   Rogério, Fábio ^a   Parada, Carlos Amilcar ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

Doublecortin; Glial fibrillary acidic protein; Quinolinic acid; Stereology; Striatum; Western Blotting

Indexed keywords

DOUBLECORTIN; GLIAL FIBRILLARY ACIDIC PROTEIN; JANUS KINASE 2; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; QUINOLINIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN DAMAGE; CELL SURVIVAL; COMPETITIVE INHIBITION; CONTROLLED STUDY; CORPUS STRIATUM; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NEUROBLAST; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; STEREOLOGY; WESTERN BLOTTING;

ANIMALS; ASTROCYTES; BLOTTING, WESTERN; CELL COUNT; CELL DEATH; ENZYME INHIBITORS; GLIAL FIBRILLARY ACIDIC PROTEIN; GLIOSIS; IMMUNOHISTOCHEMISTRY; JANUS KINASE 2; MALE; MICE; MICE, INBRED C57BL; MICROTUBULE-ASSOCIATED PROTEINS; NEOSTRIATUM; NEURODEGENERATIVE DISEASES; NEURONS; NEUROPEPTIDES; NEUROPROTECTIVE AGENTS; PHOSPHORYLATION; QUINOLINIC ACID; SIGNAL TRANSDUCTION; STAT TRANSCRIPTION FACTORS; TYRPHOSTINS;

EID: 84875501090     PISSN: 08910618     EISSN: 18736300     Source Type: Journal    
DOI: 10.1016/j.jchemneu.2013.02.005     Document Type: Article

References (57)

1. Acharya M.M., Hattiangady B., Shetty A.K. Progress in neuroprotective strategies for preventing epilepsy. Progress in Neurobiology 2008, 84:363-404.
2. Aldskogius H., Kozlova E.N. Central neuron-glial and glial-glial interactions following axon injury. Progress in Neurobiology 1998, 55:1-26.
3. Arvidsson A., Collin T., Kirik D., Kokaia Z., Lindvall O. Neuronal replacement from endogenous precursors in the adult brain after stroke. Nature Medicine 2002, 8:963-970.
4. Beal M.F., Kowall N.W., Ellison D.W., Mazurek M.F., Swartz K.J., Martin J.B. Replication of the neurochemical characteristics of Huntington's disease by quinolinic acid. Nature 1986, 321:168-171.
5. Bowman T., Garcia R., Turkson J., Jove R. STATs in oncogenesis. Oncogene 2000, 19:2474-2488.
6. Brown J.P., Couillard-Després S., Cooper-Kuhn C.M., Winkler J., Aigner L., Kuhn H.G. Transient expression of doublecortin during adult neurogenesis. Journal of Comparative Neurology 2003, 467:1-10.
7. Caceres-Cortes J.R. A potent anti-carcinoma and anti-acute myeloblastic leukemia agent, AG490. Anticancer Agents in Medicinal Chemistry 2008, 8:717-722.
8. Chvátal A., Anderová M., Neprasová H., Prajerová I., Benesová J., Butenko O., Verkhratsky A. Pathological potential of Astroglia. Physiological Research 2008, 57(Suppl. 3):S101-S110.
9. Collin T., Arvidsson A., Kokaia Z., Lindvall O. Quantitative analysis of the generation of different striatal neuronal subtypes in the adult brain following excitotoxic injury. Experimental Neurology 2005, 195:71-80.
10. Constantin G., Brocke S., Izikson A., Laudanna C., Butcher E.C. Tyrphostin AG490 a tyrosine kinase inhibitor, blocks actively induced experimental autoimmune encephalomyelitis. European Journal of Immunology 1998, 28:3523-3529.
11. Couillard-Despres S., Winner B., Schaubeck S., Aigner R., Vroemen M., Weidner N., Bogdahn U., Winkler J., Kuhn H., Aigner L. Doublecortin expression levels in adult brain reflect neurogenesis. European Journal of Neuroscience 2005, 21:1-14.
12. Damiani C.L., O'Callaghan J.P. Recapitulation of cell signaling events associated with astrogliosis using the brain slice preparation. Journal of Neurochemistry 2007, 100:720-726.
13. Davies S.J.A., Goucher D.R., Doller C., Silver J. Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. Journal of Neuroscience 1999, 19:5810-5822.
14. Desclaux M., Teigell M., Amar L., Vogel R., Gimenez Y., Ribotta M., Privat A., Mallet J. A novel and efficient gene transfer strategy reduces glial reactivity and improves neuronal survival and axonal growth in vitro. PLoS ONE 2009, 4:e6227.
15. Di Giovanni S., Movsesyan V., Ahmed F., Cernak I., Schinelli S., Stoica B., Faden A.I. Cell cycle inhibition provides neuroprotection and reduces glial proliferation and scar formation after traumatic brain injury. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:8333-8338.
16. Dihné M., Block F., Korr H., Töpper R. Time course of glial proliferation and glial apoptosis following excitotoxic CNS injury. Brain Research 2001, 902:178-189.
17. Emsley J.G., Hagg T. Endogenous and exogenous ciliary neurotrophic factor enhances forebrain neurogenesis in adult mice. Experimental Neurology 2003, 183:298-310.
18. Estrada-Sánchez A.M., Mejía-Toiber J., Massieu L. Excitotoxic neuronal death and the pathogenesis of Huntington's disease. Archives of Medical Research 2008, 39:265-276.
19. Filippo M.D., Tozzi A., Costa C., Belcastro V., Tantucci M., Picconi B., Calabresi P. Plasticity and repair in the post-ischemic brain. Neuropharmacology 2008, 55:353-362.
20. Franklin K.B.J., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 1997, Academic Press, San Diego. second ed.
21. Galvin K.A., Oorschot D.E. Continuous low-dose treatment with brain-derived neurotrophic factor or neurotrophin-3 protects striatal medium spiny neurons from mild neonatal hypoxia/ischemia: a stereological study. Neuroscience 2003, 118:1023-1032.
22. Gleeson J.G., Lin P.T., Flanagan L.A., Walsh C.A. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron 1999, 23:257-271.
23. Gordon R.J., Tattersfield A.S., Vazey E.M., Kells A.P., McGregor A.L., Hughes S.M., Connor B. Temporal profile of subventricular zone progenitor cell migration following quinolinic acid-induced striatal cell loss. Neuroscience 2007, 146:1704-1718.
24. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., Møller A., Nielsen K., Nyengaard J.R., Pakkenberg B., et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. APMIS 1988, 96:857-881.
25. Hanbury R., Ling Z.D., Wuu J., Kordower J.H. GFAP knockout mice have increased levels of GDNF that protect striatal neurons from metabolic and excitotoxic insults. Journal of Comparative Neurology 2003, 461:307-316.
26. Hansson O., Guatteo E., Mercuri N.B., Bernardi G., Li X.J., Castilho R.F., Brundin P. Resistance to NMDA toxicity correlates with appearance of nuclear inclusions behavioural deficits and changes in calcium homeostasis in mice transgenic for exon 1 of the huntington gene. European Journal of Neuroscience 2001, 14:1492-1504.
27. Hansson O., Petersén A., Leist M., Nicotera P., Castilho R.F., Brundin P. Transgenic mice expressing a Huntington's disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity. Proceedings of the National Academy of Sciences of the United States of America 1999, 96:8727-8732.
28. Haas S.J., Ahrens A., Petrov S., Schmitt O., Wree A. Quinolinic acid lesions of the caudate putamen in the rat lead to a local increase of ciliary neurotrophic factor. Journal of Anatomy 2004, 204:271-281.
29. Heinrich P.C., Behrmann I., Müller-Newen G., Schaper F., Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochemical Journal 1998, 334:297-314.
30. Herrmann J.E., Imura T., Song B., Qi J., Ao Y., Nguyen T.K., Korsak R.A., Takeda K., Akira S., Sofroniew M.V. STAT3 is a critical regulator of Astrogliosis and scar formation after Spinal Cord Injury. Journal of Neuroscience 2008, 28:7231-7243.
31. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
32. Levitzki A., Mishani E. Tyrphostins and other tyrosine kinase inhibitors. Annual Review of Biochemistry 2006, 75:93-109.
33. Luo J.M., Cen L.P., Zhang X.M., Chiang S.W., Huang Y., Lin D., Fan Y.M., van Rooijen N., Lam D.S., Pang C.P., Cui Q. PI3K/akt JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury. European Journal of Neuroscience 2007, 26:828-842.
34. Luzzati F., De Marchis S., Parlato R., Gribaudo S., Schütz G., Fasolo A., Peretto P. New striatal neurons in a mouse model of progressive striatal degeneration are generated in both the subventricular zone and the striatal parenchyma. PLoS ONE 2011, 6:e25088.
35. McLin J.P., Thompson L.M., Steward O. Differential susceptibility to striatal neurodegeneration induced by quinolinic acid and kainate in inbred outbred and hybrid mouse strains. European Journal of Neuroscience 2006, 24:3134-3140.
36. Meydan N., Grunberger T., Dadi H., Shahar M., Arpaia E., Lapidot Z., Leeder J.S., Freedman M., Cohen A., Gazit A., Levitzki A., Roifman C.M. Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitor. Nature 1996, 379:645-648.
37. Müller S., Chakrapani B.P., Schwegler H., Hofmann H.D., Kirsch M. Neurogenesis in the dentate gyrus depends on ciliary neurotrophic factor and signal transducer and activator of transcription 3 signaling. Stem Cells 2009, 27:431-441.
38. Nirmalan N.J., Harnden P., Selby P.J., Banks R.E. Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting. Journal of Pathology 2009, 217:497-506.
39. Parent J.M., Vexler Z.S., Gong C., Derugin N., Ferriero D.M. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Annals of Neurology 2002, 52:802-813.
40. Pekny M., Nilsson M. Astrocyte activation and reactive Gliosis. Glia 2005, 50:427-434.
41. Rogério F., de Souza Queiroz L., Teixeira S.A., Oliveira A.L., de Nucci G., Langone F. Neuroprotective action of melatonin on neonatal rat motoneurons after sciatic nerve transection. Brain Research 2002, 926:33-41.
42. Roitbak T., Syková E. Diffusion barriers evoked in the rat cortex by reactive astrogliosis. Glia 1999, 28:40-48.
43. Romero-Calvo I., Ocón B., Martínez-Moya P., Suárez M.D., Zarzuelo A., Martínez-Augustin O., de Medina F.S. Reversible Ponceau staining as a loading control alternative to actin in Western blots. Analytical Biochemistry 2010, 401:318-320.
44. Ryu J.K., Kim S.U., McLarnon J.G. Blockade of quinolinic acid-induced neurotoxicity by pyruvate is associated with inhibition of glial activation in a model of Huntington's disease. Experimental Neurology 2004, 187:150-159.
45. Satriotomo I., Bowen K.K., Vemuganti R. JAK2 and STAT3 activation contributes to neuronal damage following transient focal cerebral ischemia. Journal of Neurochemistry 2006, 98:1353-1368.
46. Schiefer J., Töpper R., Schmidt W., Block F., Heinrich P.C., Noth J., Schwarz M. Expression of interleukin 6 in the rat striatum following stereotaxic injection of quinolinic acid. Journal of Neuroimmunology 1998, 89:168-176.
47. Schwarcz R., Guidetti P., Sathyasaikumar K.V., Muchowski P.J. Of mice, rats and men Revisiting the quinolinic acid hypothesis of Huntington's disease. Progress in Neurobiology 2010, 90:230-245.
48. Silver J., Miller J.H. Regeneration beyond the glial scar. Nature Reviews Neuroscience 2004, 5:146-156.
49. Sofroniew M.V. Reactive astrocytes in neural repair and protection. Neuroscientist 2005, 11:400-407.
50. Sriram K., Benkovic S.A., Hebert M.A., Miller D.B., Callaghan J.P. Induction of gp130-related cytokines and activation of JAK2/STAT3 pathway in astrocytes precedes up-regulation of glial fibrillary acidic protein in the 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of neurodegeneration. Journal of Biological Chemistry 2004, 279:19936-19947.
51. Su Z., Yuan Y., Cao L., Zhu Y., Gao L., Qiu Y., He C. Triptolide promotes spinal cord repair by inhibiting astrogliosis and inflammation. Glia 2010, 58:901-915.
52. Tattersfield A.S., Croon R.J., Liu Y.W., Kells A.P., Faull R.L.M., Connor B. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease. Neuroscience 2004, 127:319-332.
53. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proceedings of the National Academy of Sciences of the United States of America 1979, 76:4350-4354.
54. Vieira A.S., Rezende A.C., Grigoletto J., Rogério F., Velloso L.A., Skaper S.D., Negro A., Langone F. Ciliary neurotrophic factor infused intracerebroventricularly shows reduced catabolic effects when linked to the TAT protein transduction domain. Journal of Neurochemistry 2009, 110:1557-1566.
55. West M.J., Slomianka L., Gundersen H.J. Unbiased stereological estimation of the total number of neurons in the subdivisions of the rat hippocampus using the optical fractionator. Anatomical Record 1991, 231:482-497.
56. Yan Y.P., Lang B.T., Vemuganti R., Dempsey R.J. Osteopontin is a mediator of the lateral migration of neuroblasts from the subventricular zone after focal cerebral ischemia. Neurochemistry International 2009, 55:826-832.
57. Yang H.K., Sundholm-Peters N.L., Goings G.E., Walker A.S., Hyland K., Szele F.G. Distribution of doublecortin expressing cells near the lateral ventricles in the adult mouse brain. Journal of Neuroscience Research 2004, 76:282-295.